0001671858-16-000003.txt : 20161130 0001671858-16-000003.hdr.sgml : 20161130 20161129195219 ACCESSION NUMBER: 0001671858-16-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161130 DATE AS OF CHANGE: 20161129 EFFECTIVENESS DATE: 20161130 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Silverback Therapeutics, Inc. CENTRAL INDEX KEY: 0001671858 IRS NUMBER: 811489190 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-275309 FILM NUMBER: 162023831 BUSINESS ADDRESS: STREET 1: 14075 NE 30TH PLACE CITY: BELLEVUE STATE: WA ZIP: 98007 BUSINESS PHONE: 212-739-6451 MAIL ADDRESS: STREET 1: 14075 NE 30TH PLACE CITY: BELLEVUE STATE: WA ZIP: 98007 D 1 primary_doc.xml X0707 D LIVE 0001671858 Silverback Therapeutics, Inc. 500 Fairview Avenue North Suite 600 Seattle WA WASHINGTON 98109 206-456-2900 DELAWARE None None Corporation true 2016 Peter A. Thompson 500 Fairview Avenue North Suite 600 Seattle WA WASHINGTON 98109 Executive Officer Director Biotechnology Decline to Disclose 06b false true false true false 0 25000 0 25000 false 0 0 0 0 false Silverback Therapeutics, Inc. Jill E. Fishbein Jill E. Fishbein Secretary 2016-11-29